BioGend Therapeutics Co., Ltd. (TPEX:6733)

Taiwan · Delayed Price · Currency is TWD

33.75

-0.20 (-0.59%)

Mar 24, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	222.34M	167.65M	109.91M	31.45M	9.27M
Pharmaceuticals Growth	32.62%	52.53%	249.51%	239.26%	565.40%
Total	222.34M	167.65M	109.91M	31.45M	9.27M
Total Growth	32.62%	52.53%	249.51%	239.26%	565.40%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Other	-	2.50M	101.00K	300.00K	-
Other Growth	-	2375.25%	-66.33%	-	-
Malaysia	1.43M	1.90M	-	-	-
Malaysia Growth	-25.00%	-	-	-	-
Hong Kong and Chinese Mainland	2.22M	1.14M	-	-	-
Hong Kong and Chinese Mainland Growth	95.17%	-	-	-	-
Taiwan	218.69M	161.41M	73.54M	31.14M	8.99M
Taiwan Growth	35.48%	119.50%	136.18%	246.22%	878.56%
Japan	-	696.00K	24.88M	10.00K	-
Japan Growth	-	-97.20%	248700.00%	-	-
China	-	-	11.39M	-	-
America	-	-	-	-	276.00K
America Growth	-	-	-	-	-41.77%
Total	222.34M	167.65M	109.91M	31.45M	9.27M
Total Growth	32.62%	52.53%	249.51%	239.26%	565.40%

Source: S&P Global Market Intelligence.